The most promising near-term application of circulating tumor cells (CTCs) monitoring
relates to the development of targeted cancer therapies, and the need to tailor such …

Circulating tumor cells (CTCs) have emerged as a viable solution to the lack of tumor tissue
availability for patients with a variety of solid tumors, including prostate cancer. Different …

Circulating tumor cells (CTCs) provide accurate information on the clinical stage of cancer
progression. The present study examined the clinical validity and feasibility of a new medical …

Prostate cancer is a life-threatening and highly heterogeneous malignancy. In the past
decade, circulating tumor cells (CTCs) have been suggested to play a critical role in the …

Background and Methods Circulating tumor cells (CTCs) constitute a useful approach for
personalized medicine. Nevertheless, the isolation of these cells remains very challenging …

As the presence of tumor cells circulating in the blood is associated with systemic disease
and shortened survival, the establishment of a method to detect circulating tumor cells …

Given the low specificity of the routinely used biomarker prostate-specific antigen, circulating
tumor cell (CTC) enumeration seems to be particularly useful in the monitoring of prostate …

Introduction Circulating tumor cells (CTCs) can provide important information on patient's
prognosis and treatment efficacy. Currently, a plethora of methods is available for the …

Circulating tumor cells (CTCs) are tumor cells found in the peripheral blood that putatively
originate from established sites of malignancy and likely have metastatic potential. Analysis …

It is believed that the development of metastatic cancer requires the presence of circulating
tumor cells (CTCs), which are found in a patient's circulation as rare abnormal cells …